Cell-mediated immunity against allogeneic tumor after in vitro depletion of histocompatibility reactive cells (38552).
D000818:Animals; D000921:Antibody-Producing Cells; D000951:Antigens, Neoplasm / Q000032:analysis*; D005260:Female; D005354:Fibrosarcoma / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D006084:Graft Rejection; D006649:Histocompatibility Antigens; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007959:Lymphocyte Culture Test, Mixed; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*; D009500:Neutralization Tests; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D012513:Sarcoma, Experimental / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D013154:Spleen / Q000276:immunology; D013936:Thymidine; D014184:Transplantation, Homologous; D014316:Tritium
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D014316:Tritium; D013936:Thymidine